T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 2, 2010, Pages 170-178

  Iclozan, Cristina ^a   Yu, Yu ^a   Liu, Chen ^b   Liang, Yaming ^a   Yi, Tangsheng ^c   Anasetti, Claudio ^a,d   Yu, Xue Zhong ^a,d  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

BMT; GVHD; Th1; Th17

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ROR GAMMA T; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL DISRUPTION; CELL EXPANSION; CELL INFILTRATION; CELL POLARITY; CELL SURVIVAL; CONTROLLED STUDY; GRAFT RECIPIENT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENICITY; TH1 CELL; TH17 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WHOLE BODY IMAGING;

EID: 75149118145     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.09.023     Document Type: Article

References (35)

1. Appelbaum F.R. Haematopoietic cell transplantation as immunotherapy. Nature 411 (2001) 385-389
2. Blazar B.R., and Murphy W.J. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci 360 (2005) 1747-1767
3. Harrington L.E., Hatton R.D., Mangan P.R., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
4. Park H., Li Z., Yang X.O., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
5. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
6. Mangan P.R., Harrington L.E., O'Quinn D.B., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
7. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
8. Chen X., Das R., Komorowski R., et al. Blockade of interleukin-6 signaling augments regulatory T cell reconstitution and attenuates the severity of graft versus host disease. Blood 114 (2009) 891-900
9. Ivanov II, McKenzie B.S., Zhou L., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 126 (2006) 1121-1133
10. Yang X.O., Panopoulos A.D., Nurieva R., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282 (2007) 9358-9363
11. Yang X.O., Pappu B.P., Nurieva R., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28 (2008) 29-39
12. Ferrara J.L. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 5 (1993) 794-799
13. Krenger W., Hill G.R., and Ferrara J.L. Cytokine cascades in acute graft-versus-host disease. Transplantation 64 (1997) 553-558
14. Via C.S., Rus V., Gately M.K., and Finkelman F.D. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol 153 (1994) 4040-4047
15. Williamson E., Garside P., Bradley J.A., and Mowat A.M. IL-12 is a central mediator of acute graft-versus-host disease in mice. J Immunol 157 (1996) 689-699
16. Carlson M.J., West M.L., Coghill J.M., Panoskaltsis-Mortari A., Blazar B.R., and Serody J.S. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 113 (2009) 1365-1374
17. Kappel L.W., Goldberg G.L., King C.G., et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 113 (2009) 945-952
18. Yi T., Zhao D., Lin C.L., et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 112 (2008) 2101-2110
19. Edinger M., Hoffmann P., Ermann J., et al. CD4 + CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9 (2003) 1144-1150
20. Liang Y., Liu C., Djeu J.Y., et al. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. Blood 111 (2008) 954-962
21. Negrin R.S., and Contag C.H. In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nat Rev 6 (2006) 484-490
22. Yu Y., Iclozan C., Yamazaki T., et al. Abundant c-FLIP expression determines resistance of Th17 cells to activation-induced cell death. Blood 114 (2009) 1026-1028
23. Yu X.Z., Bidwell S.J., Martin P.J., and Anasetti C. Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens. J Immunol 166 (2001) 5835-5839
24. Murphy W.J., Welniak L.A., Taub D.D., et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 102 (1998) 1742-1748
25. Nikolic B., Lee S., Bronson R.T., Grusby M.J., and Sykes M. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 105 (2000) 1289-1298
26. Yang Y.G., Dey B.R., Sergio J.J., Pearson D.A., and Sykes M. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest 102 (1998) 2126-2135
27. Burman A.C., Banovic T., Kuns R.D., et al. IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood 110 (2007) 1064-1072
28. Mauermann N., Burian J., von Garnier C., et al. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17 + CD4 + T-cell-mediated graft-versus-host disease. Am J Respir Crit Care Med 178 (2008) 379-388
29. Nurieva R., Yang X.O., Chung Y., and Dong C. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J Immunol 182 (2009) 2565-2568
30. Yang X.O., Nurieva R., Martinez G.J., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29 (2008) 44-56
31. Qian Y., Liu C., Hartupee J., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8 (2007) 247-256
32. Lohr J., Knoechel B., Wang J.J., Villarino A.V., and Abbas A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203 (2006) 2785-2791
33. Muranski P., Boni A., Antony P.A., et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112 (2008) 362-373
34. Nakae S., Iwakura Y., Suto H., and Galli S.J. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 81 (2007) 1258-1268
35. Yi T., Chen Y., Wang L., et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft versus host disease. Blood 114 (2009) 3101-3112